Page 34 - Haematologica3

J.T. Butler et al.
Wagner W, editor. PLoS One. 2016;11(2):
e0146722.
72. Corrado C, Saieva L, Raimondo S, Santoro
81.Hornick NI, Huan J, Doron B, et al. Serum exosome microRNA as a minimally-invasive early biomarker of AML. Sci Rep. 2015;5:11295.
82. Khalyfa A, Khalyfa AA, Akbarpour M, et al. Extracellular microvesicle microRNAs in children with sickle cell anaemia with diver- gent clinical phenotypes. Br J Haematol. 2016;174(5):786–798.
83. Hosokawa K, Kajigaya S, Feng X, et al. A plasma microRNA signature as a biomarker for acquired aplastic anemia. Haematologica. 2017;102(1):69–78.
84.Lin M-C, Chen S-Y, Tsai H-M, et al. PGE2 /EP4 signaling controls the transfer of the mammary stem cell state by lipid rafts in extracellular vesicles. Stem Cells. 2017;35 (2):425–444.
85. Di Trapani M, Bassi G, Midolo M, et al. Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions. Sci Rep. 2016;6(1):24120.
86. Amarnath S, Foley JE, Farthing DE, et al. Bone marrow-derived mesenchymal stro- mal cells harness purinergenic signaling to tolerize human Th1 cells in vivo. Stem Cells. 2015;33(4):1200–1212.
87. Kordelas L, Rebmann V, Ludwig A-K, et al. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia. 2014;28(4):970–973.
88. Alexander M, Ramstead AG, Bauer KM, et al. Rab27-dependent exosome production inhibits chronic inflammation and enables acute responses to inflammatory stimuli. J Immunol. 2017;199(10):3559–3570.
89. Boyd AL, Campbell CJ, Hopkins CI, et al. Niche displacement of human leukemic stem cells uniquely allows their competitive replacement with healthy HSPCs. J Exp Med. 2014;211(10):1925–1935.
90. Shiozawa Y, Pedersen EA, Havens AM, et al. Human prostate cancer metastases target the hematopoietic stem cell niche to estab- lish footholds in mouse bone marrow. J Clin Invest. 2011;121(4):1298–1312.
91. Yu X, Harris SL, Levine AJ. The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res. 2006;66(9):4795– 4801.
92. Bondar T, Medzhitov R. p53-mediated
hematopoietic stem and progenitor cell
competition. Stem Cell. 2010;6(4):309–322. 93. Slaughter DP, Southwick HW, Smekjal W. Field cancerization in oral stratified squa- mous epithelium; clinical implications of multicentric origin. Cancer. 1953;6(5):963–
968.
94.Dhawan A, Bonin von M, Bray LJ, et al.
Functional interference in the bone marrow microenvironment by disseminated breast cancer cells. Stem Cells. 2016;34(8):2224– 2235.
95. Jung Y, Wang J, Havens A, et al. Cell-to-cell contact is critical for the survival of hematopoietic progenitor cells on osteoblasts. Cytokine. 2005;32(3-4):155– 162.
96. Heidt T, Sager HB, Courties G, et al. Chronic variable stress activates hematopoietic stem cells. Nat Med. 2014;20(7):754–758.
97. Alexander M, Hu R, Runtsch MC, et al. Exosome-delivered microRNAs modulate the inflammatory response to endotoxin. Nat Commun. 2015;6:7321.
98. Ridder K, Keller S, Dams M, et al. Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation. PLoS Biol. 2014; 12(6):1001874.
99. Dai J, Lu Y, Wang C, et al. Vps33b regulates Vwf-positive vesicular trafficking in megakaryocytes. J Pathol. 2016;240(1):108– 119.
100. Zhi F, Cao X, Xie X, et al. Identification of circulating microRNAs as potential bio- markers for detecting acute myeloid leukemia. PLoS One. 2013;8(2):56718.
101.Yeh Y-Y, Ozer HG, Lehman AM, et al. Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling. Blood. 2015;125(21):3297–3305.
102. van Eijndhoven MA, Zijlstra JM, Groenewegen NJ, et al. Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients. JCI Insight. 2016;1(19):89631.
103.Manier S, Liu C-J, Avet-Loiseau H, et al. Prognostic role of circulating exosomal miRNAs in multiple myeloma. Blood. 2017;129(17):2429–2436.
A, De Leo G, Alessandro R. Chronic myel- ogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor. J Cell Mol Med. 2016;20(10):1829–1839.
73. Peinado H, Alečković M, Lavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012;18(6):883–891.
74. Burnouf T, Chou M-L, Goubran H, Cognasse F, Garraud O, Seghatchian J. An overview of the role of microparticles/ microvesicles in blood components: are they clinically beneficial or harmful? Transfus Apher Sci. 2015;53(2): 137–145.
75. Caivano A, Laurenzana I, De Luca L, et al. High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders. Tumour Biol. 2015;36(12):9739–9752.
76. Caivano A, La Rocca F, Laurenzana I, et al. Extracellular vesicles in hematological malig- nancies: from biology to therapy. Int J Mol Sci. 2017;18(6):1183.
77.Belov L, Matic KJ, Hallal S, Best OG, Mulligan SP, Christopherson RI. Extensive surface protein profiles of extracellular vesi- cles from cancer cells may provide diagnos- tic signatures from blood samples. J Extracell Vesicles. 2016;5(1):e25355.
78.De Luca L, D'Arena G, Simeon V, et al. Characterization and prognostic relevance of circulating microvesicles in chronic lym- phocytic leukemia. Leuk Lymphoma. 2017;58(6):1424–1432.
79. Harshman SW, Canella A, Ciarlariello PD, et al. Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers. J Proteomics. 2016;136:89–98.
80. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654– 659.
394
haematologica | 2018; 103(3)